Motivational Interventions & Physical Exercise in Patients With Fragility

Status Recruiting

Clinical Trial Summary

Patients with a fragility fracture are twice as likely to have future fractures compared to their non-fractured peers. Furthermore, the 30% who suffer a fragility fracture do not regain the level of functioning in terms of activities of daily living after one year. A recent ecological study, in several European countries, estimates that if fracture patients were enrolled in fracture follow-up services, at least 19,000 fractures could be prevented each year. Clinical trials carried out in the research group have shown that the prescription of physical exercise in severe underlying pathologies is effective in improving physical function, quality of life and long-term results. Hypothesis: The implementation of a motivational intervention and physical exercise program, in a staggered manner, taking into account the basic exercise capacity, improves the functional status of the patient (basic activities of daily life), adherence to interventions and the level of physical activity, and therefore reduces the number of hospital admissions, refractures and other associated complications. Objective: To evaluate the effect of a rehabilitation intervention based on physical exercise and motivation, applied in a staggered manner and according to the functional capacity of patients with fragility fracture.

Clinical Trial Description

Method: Single-blind, randomized, controlled clinical study, with 2 parallel arms and single-center. Study subjects: Patients who underwent surgery for a fragility hip fracture between September 2021 and September 2022 in a tertiary hospital in southern Spain. A progressive physical exercise and motivational intervention adjusted for functional capacity will be compared versus usual rehabilitation care. Follow-up of patients for 3 months and a final visit at 6 months. The primary outcome variables will be functional status for the development of activities of daily living (individual ability to care for himself) and number of hospital readmissions (reasons and consequences). Variables related to quality of life, cognitive status, laboratory markers and densitometry will also be analyzed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04934358
Study type	Interventional
Source	Maimónides Biomedical Research Institute of Córdoba
Contact
Status	Recruiting
Phase	N/A
Start date	January 10, 2022
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05845021` - Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty	N/A
Recruiting	`NCT05426356` - Sacral Fracture Fusion/Fixation for Rapid Rehabilitation	N/A
Recruiting	`NCT05489952` - Iron Supplementation for Geriatric Hip Fractures	Phase 4
Active, not recruiting	`NCT04654962` - Use of Anesthetic Block for the Prevention of in Hospital Delirium in Patients of the Orthogeriatric Clinical Care Center of the HUFSFB and HUSJI From 2019 - 2020
Recruiting	`NCT04787679` - Image-guided Computational and Experimental Analyses of Fractured Patient's Bone (GAP)
Recruiting	`NCT06134908` - PRevention of OsTEoporotiC FracTure 2 Pilot Study	N/A
Active, not recruiting	`NCT05269979` - Hip Fracture Prevention Follow-up of Elderly Women in Primary Health Care	N/A
Recruiting	`NCT04657510` - Femoral frACturEs and COVID-19.
Not yet recruiting	`NCT06054165` - Impact of a Clinical Pathway for Pelvic Fragility Fractures	N/A
Recruiting	`NCT05712616` - Role of Strontium Ranelate in Proximal Femur Fragility Fractures.	Phase 4
Not yet recruiting	`NCT05837182` - The Role of Augmented Fixation Techniques in Fragility Fracture Pelvis (FFP)
Recruiting	`NCT05096195` - PRevEnting FracturEs in REnal Disease 1	Phase 4
Completed	`NCT05721898` - Assessment of Cortical Bone Mechanics Technology (CBMT) Fracture Discrimination Capability
Not yet recruiting	`NCT06050668` - Essential Amino Acid Supplementation for Femoral Fragility Fractures	N/A
Recruiting	`NCT05851898` - Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures	Phase 4
Recruiting	`NCT04796350` - RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Motivational Interventions and Physical Exercise in Patients With Fragility Fracture — PREVFRAILTY

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms